Akoya Biosciences, Inc.
AKYA · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$15,652 | -$8,199 | -$10,533 | -$13,149 |
| Dep. & Amort. | $1,798 | $1,852 | $1,825 | $1,926 |
| Deferred Tax | $11 | -$71 | $38 | $0 |
| Stock-Based Comp. | $2,246 | $2,146 | $1,881 | $2,713 |
| Change in WC | $3,146 | $506 | $12,003 | -$3,788 |
| Other Non-Cash | $1,237 | $784 | -$14,470 | $1,257 |
| Operating Cash Flow | -$7,214 | -$2,982 | -$9,256 | -$11,041 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$204 | -$1,042 | -$434 | -$170 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$3,752 | -$16,965 | -$17,545 | -$21,776 |
| Inv. Sales/Matur. | $20,000 | $20,700 | $30,998 | $31,000 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $16,044 | $2,693 | $13,019 | $9,054 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$180 | -$502 | -$166 | -$173 |
| Stock Issued | $7 | $16 | $16 | $23 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $7 | $0 | $0 | -$1,975 |
| Financing Cash Flow | -$250 | -$486 | -$150 | -$2,125 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $8,580 | -$775 | $3,613 | -$4,112 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $12,465 | $13,240 | $9,627 | $13,739 |
| End Cash | $21,045 | $12,465 | $13,240 | $9,627 |
| Free Cash Flow | -$7,418 | -$4,024 | -$9,690 | -$11,211 |